From: Menopausal state and rheumatoid arthritis: a systematic review and meta-analysis
Author | Year | Country | Number of participants | Study design | Outcome | Comparison group | OR (95%CI) | QA |
---|---|---|---|---|---|---|---|---|
Neda Ghamarzad Shishavan, et al. [20] | 2016 | Iran | 469 | Case-control | RA | Post-menopause/Pre-menopause | 2.97(1.98–4.46) | Low risk |
Lauren E. et al. [26] | 2015 | Canada | 534 | Cohort | RA | Early menopas/ normal menopas | 2.20(1.30–3.80) | Low risk |
Mitra Pikwer, et al. [27] | 2011 | Sweden | 30,447 | Cohort | RA | Post-menopause/Pre-menopause | 2.42(1.32–4.45) | Low risk |
Yeonghee Eun et al. [22] | 2020 | South Korea | 6056 | Cohort | RA | Post-menopause/Pre-menopause | 0.96(0.79–1.17) | Low risk |
Camilla Bengtsson, et al. | 2017 | USA | 121,700 | Cohort | RA | Early menopas/ normal menopas | 2.41(1.50-4.0) | Low risk |
Camilla Bengtsson, et al. [23] | 2017 | USA | 116,430 | Cohort | RA | Post-menopause/Pre-menopause | 2.79(1.76–3.81) | Low risk |
Linda A. Merlino, et al. [8] | 2003 | USA | 31,336 | Cohort | RA | Post-menopause/Pre-menopause | 0.80(0.51–1.25) | Low risk |
Mitra Pikwer, et al. [21] | 2012 | Sweden | 134 | Case-control | RA | Early menopause((≤ 45 years)/ normal menopause | 4.51(3.59–5.43) | Low risk |
Beydoun, et al. [28] | 2013 | USA | 1892 | Cross-sectional data from the Third National Health and Nutrition Examination Survey | RA | Early menopas/ normal menopas | 2.53(1.41–4.53) | Low risk |
Szoeke, et al. [24] | 2005 | Australia | 1897 | Cross-sectional population-based survey | RA | Post-menopause/Pre-menopause | 1.88(1.33–2.66) | Low risk |
Jingjing Zhu1, et al. [25] | 2021 | UK | 329,345 | survey | RA | Post-menopause/Pre-menopause | 1.05(0.98–1.11) | Low risk |